The economic burden of long term neurological conditions pathways is difficult to quantify. With the ambition to deliver care differently through digital mechanisms, and enhancing provision of self-management support, it is imperative that we develop mechanisms to measure the economic impact of pathway interventions. An impact inventory is a recognised initial step in defining the costs of an intervention from a range of perspectives. Survey data from the NeuroLTC study was thematically analysed to identify frequency of event categories, associated care activities identified and estimated pathway costs calculated.
Chris is a Consultant Neurologist with subspecialty interest in behavioural neurology and cognitive disorders, and Professor of Clinical Neurology and Dementia at University Hospital Southampton and the University of Southampton. He leads the Cognitive Disorders service at the Wessex Neurological Centre.
Chris is Clinical Director for Research and Development at...